Aligos Therapeutics Announces 1-for-25 Reverse Stock Split Effective August 19, 2024
Portfolio Pulse from Benzinga Newsdesk
Aligos Therapeutics has announced a 1-for-25 reverse stock split effective August 19, 2024. The company's common stock will begin trading on the Nasdaq Capital Market under the symbol ALGS with a new CUSIP number 01626L 204.
August 15, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Aligos Therapeutics is implementing a 1-for-25 reverse stock split effective August 19, 2024. This action will consolidate shares and may impact stock liquidity and price.
A reverse stock split reduces the number of shares outstanding, which can lead to an increase in the stock price. However, it may also reduce liquidity. Investors should monitor the stock closely as the market reacts to this change.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100